| Product NDC: | 58118-2108 |
| Proprietary Name: | Amlodipine Besylate |
| Non Proprietary Name: | amlodipine besylate |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; amlodipine besylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58118-2108 |
| Labeler Name: | Clinical Solutions Wholesale |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078414 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100407 |
| Package NDC: | 58118-2108-0 |
| Package Description: | 1 TABLET in 1 PACKAGE (58118-2108-0) |
| NDC Code | 58118-2108-0 |
| Proprietary Name | Amlodipine Besylate |
| Package Description | 1 TABLET in 1 PACKAGE (58118-2108-0) |
| Product NDC | 58118-2108 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amlodipine besylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100407 |
| Marketing Category Name | ANDA |
| Labeler Name | Clinical Solutions Wholesale |
| Substance Name | AMLODIPINE BESYLATE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |